Advertisement
UK markets open in 1 hour 54 minutes

  • NIKKEI 225

    38,396.27
    +844.11 (+2.25%)
     

  • HANG SENG

    17,110.21
    +281.28 (+1.67%)
     

  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     

  • GOLD FUTURES

    2,339.30
    -2.80 (-0.12%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,814.54
    +542.16 (+1.02%)
     

  • CMC Crypto 200

    1,442.99
    +28.23 (+2.00%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

AstraZeneca says new lung cancer pill Tagrisso approved by EU

Reuters - UK Focus

LONDON, Feb 3 (Reuters) - AstraZeneca (NYSE: AZN - news) said its new lung cancer pill Tagrisso won early approval for use in the EU, three months after U.S (Other OTC: UBGXF - news) . authorities gave it the green light, in a boost for the company.

Tagrisso, also known as AZD9291, is one of several cancer medicines AstraZeneca hopes will rebuild its sales following patent losses on older drugs. During its defence against a takeover attempt by Pfizer (NYSE: PFE - news) in 2014, the firm forecast the drug could eventually achieve sales of $3 billion a year.

The company said on Wednesday that the European Commission granted conditional marketing authorisation for Tagrisso to treat patients with a certain type of lung cancer.

AstraZeneca said the drug was the first to be approved under the regulator's expedited process. (Reporting by Sarah Young, editing by James Davey)